Literature DB >> 1287813

Cerebrospinal fluid levels of IL-6 in patients with acute infections of the central nervous system.

D Torre1, C Zeroli, G Ferraro, F Speranza, R Tambini, R Martegani, G P Fiori.   

Abstract

Interleukin-6 (IL-6) activity was measured in the cerebrospinal fluid (CSF) of patients with acute bacterial or viral meningitis and in AIDS patients with various cerebral disorders. Increased levels of IL-6 were detected in the CSF of patients with bacterial meningitis. On the contrary, most of the samples from patients with viral meningitis (predominantly caused by mumps virus) had no detectable IL-6 activity in CSF. A moderate increase of IL-6 levels was detected in the CSF of AIDS patients with AIDS dementia complex (ADC), progressive multifocal leukoencephalopathy and cerebral toxoplasmosis. Moreover, higher levels of IL-6 were detected in the CSF of patients with cryptococcal meningitis. We conclude that the initial events of CSF inflammation in patients with acute viral meningitis are different from those in patients with acute bacterial meningitis, and the role of IL-6 is less critical to the process.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1287813     DOI: 10.3109/00365549209062465

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  10 in total

1.  Role for tumor necrosis factor-α in JC virus reactivation and progressive multifocal leukoencephalopathy.

Authors:  Hassen S Wollebo; Mahmut Safak; Luis Del Valle; Kamel Khalili; Martyn K White
Journal:  J Neuroimmunol       Date:  2010-12-24       Impact factor: 3.478

2.  Interleukin-8 levels in children with bacterial, tuberculous and aseptic meningitis.

Authors:  Erdal Yilmaz; M Kaya Gürgöze; Nevin Ilhan; Yaşar Doğan; Hakan Aydinoğlu
Journal:  Indian J Pediatr       Date:  2002-03       Impact factor: 1.967

3.  Accuracy of cerebrospinal fluid IL-6 testing for diagnosis of lupus psychosis. A multicenter retrospective study.

Authors:  Shunsei Hirohata; Yoshinori Kanai; Akiko Mitsuo; Yoshiaki Tokano; Hiroshi Hashimoto
Journal:  Clin Rheumatol       Date:  2009-07-12       Impact factor: 2.980

4.  Cerebrospinal fluid levels of interleukin-6 and interleukin-12 in children with meningitis.

Authors:  Chia-Chang Hsieh; Jen-Her Lu; Shu-Jen Chen; Cheng-Chou Lan; Wen-Chi Chow; Ren-Bin Tang
Journal:  Childs Nerv Syst       Date:  2008-09-25       Impact factor: 1.475

5.  STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier.

Authors:  Anathbandhu Chaudhuri; Bo Yang; Howard E Gendelman; Yuri Persidsky; Georgette D Kanmogne
Journal:  Blood       Date:  2007-11-14       Impact factor: 22.113

6.  HIV-1 gp120 induces cytokine expression, leukocyte adhesion, and transmigration across the blood-brain barrier: modulatory effects of STAT1 signaling.

Authors:  Bo Yang; Sidra Akhter; Anathbandhu Chaudhuri; Georgette D Kanmogne
Journal:  Microvasc Res       Date:  2008-11-28       Impact factor: 3.514

7.  Serum procalcitonin and cerebrospinal fluid cytokines level in children with meningitis.

Authors:  Erdal Taskin; Mehmet Turgut; Mehmet Kilic; Handan Akbulut; A Denizmen Aygun
Journal:  Mediators Inflamm       Date:  2004-08       Impact factor: 4.711

8.  Genetic polymorphisms associated with the inflammatory response in bacterial meningitis.

Authors:  Fabrícia Lima Fontes; Luíza Ferreira de Araújo; Leonam Gomes Coutinho; Stephen L Leib; Lucymara Fassarella Agnez-Lima
Journal:  BMC Med Genet       Date:  2015-08-28       Impact factor: 2.103

9.  Murine Model of Primary Acquired Ocular Toxoplasmosis: Fluorescein Angiography and Multiplex Immune Mediator Profiles in the Aqueous Humor.

Authors:  Kexin Li; Xue Feng; Kenji Hikosaka; Kazumi Norose
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-03-01       Impact factor: 4.799

10.  Evaluation of IL-6 and High Sensitive C Reactive Protein Value in CSF and Serum Children Suspected Meningitis Referred to Pediatric Emergency Room.

Authors:  Abdolkarim Hamedi; Hosain Ayatollahi; Alireza Ataee Nakhaee
Journal:  Iran Red Crescent Med J       Date:  2012-12-06       Impact factor: 0.611

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.